{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T04:14:45Z","timestamp":1686716085379},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00393-023-01338-1","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T12:02:23Z","timestamp":1685620943000},"page":"389-403","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarkoidose","Sarcoidosis"],"prefix":"10.1007","volume":"82","author":[{"given":"Raoul","family":"Bergner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","volume":"48","author":"EV Arkema","year":"2016","unstructured":"Arkema\u00a0EV, Grunewald\u00a0J, Kullberg\u00a0S et al (2016) Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir\u00a0J 48:1690\u20131699. https:\/\/doi.org\/10.1183\/13993003.00477-2016","journal-title":"Eur Respir J"},{"key":"1338_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","volume":"13","author":"O Dumas","year":"2016","unstructured":"Dumas\u00a0O, Abramovitz\u00a0L, Wiley\u00a0AS et\u00a0al (2016) Epidemiology of sarcoidosis in a\u00a0prospective cohort study of U.S. Women. Ann Am Thorac Soc 13:67\u201371. https:\/\/doi.org\/10.1513\/AnnalsATS.201508-568BC","journal-title":"Ann Am Thorac Soc"},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1164\/arrd.1984.130.1.29","volume":"130","author":"G Hillerdal","year":"1984","unstructured":"Hillerdal\u00a0G, N\u00f6u\u00a0E, Osterman\u00a0K, Schmekel\u00a0B (1984) Sarcoidosis: epidemiology and prognosis. Am Rev Respir Dis 130:29\u201332. https:\/\/doi.org\/10.1164\/arrd.1984.130.1.29","journal-title":"Am Rev Respir Dis"},{"key":"1338_CR4","first-page":"50","volume":"7","author":"N Milman","year":"1990","unstructured":"Milman\u00a0N, Selroos\u00a0O (1990) Pulmonary sarcoidosis in the Nordic countries 1950\u20131982. Epidemiology and clinical picture. Sarcoidosis 7:50\u201357","journal-title":"Sarcoidosis"},{"key":"1338_CR5","first-page":"61","volume":"12","author":"A Pietinalho","year":"1995","unstructured":"Pietinalho\u00a0A, Hiraga\u00a0Y, Hosoda\u00a0Y et\u00a0al (1995) The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis 12:61\u201367","journal-title":"Sarcoidosis"},{"key":"1338_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","volume":"91","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert\u00a0P, Carmona\u00a0EM, Utz\u00a0JP et al (2016) Epidemiology of Sarcoidosis 1946\u20132013: a population-based study. Mayo Clin Proc 91:183\u2013188. https:\/\/doi.org\/10.1016\/j.mayocp.2015.10.024","journal-title":"Mayo Clin Proc"},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.36141\/svdld.v37i1.7660","volume":"37","author":"MH Jeon","year":"2020","unstructured":"Jeon\u00a0MH, Kang\u00a0T, Yoo\u00a0SH et al (2020) The incidence, comorbidity and mortality of sarcoidosis in korea, 2008\u20132015: a nationwide population-based study. Sarcoidosis Vasc Diffuse Lung Dis 37:24\u201336. https:\/\/doi.org\/10.36141\/svdld.v37i1.7660","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"1338_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0871-3","author":"HY Yoon","year":"2018","unstructured":"Yoon\u00a0HY, Kim\u00a0HM, Kim\u00a0YJ, Song\u00a0JW (2018) Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir Res. https:\/\/doi.org\/10.1186\/s12931-018-0871-3","journal-title":"Respir Res"},{"key":"1338_CR9","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman\u00a0RP, Teirstein\u00a0AS, Judson\u00a0MA et\u00a0al (2001) Clinical characteristics of patients in a\u00a0case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885\u20131889. https:\/\/doi.org\/10.1164\/ajrccm.164.10.2104046","journal-title":"Am J Respir Crit Care Med"},{"key":"1338_CR10","doi-asserted-by":"publisher","first-page":"107121","DOI":"10.1016\/j.rmed.2023.107121","volume":"209","author":"R Bergner","year":"2023","unstructured":"Bergner R, Weiner SM, Kehl G, de Groot K, Tielke S, Asendorf T, Korsten P (2023) Renal disease in sarcoidosis patients in a German multicentric retrospective cohort study. Respir Med 209:107121. https:\/\/doi.org\/10.1016\/j.rmed.2023.107121","journal-title":"Respir Med"},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/nejmra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent\u00a0M, Crouser\u00a0ED, Grunewald\u00a0J (2021) Challenges of Sarcoidosis and its management. N\u00a0Engl J Med 385:1018\u20131032. https:\/\/doi.org\/10.1056\/nejmra2101555","journal-title":"N Engl J Med"},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MCP.0000000000000498","volume":"24","author":"ED Crouser","year":"2018","unstructured":"Crouser\u00a0ED (2018) Role of imbalance between Th17 and regulatory T\u2011cells in sarcoidosis. Curr Opin Pulm Med 24:521\u2013526. https:\/\/doi.org\/10.1097\/MCP.0000000000000498","journal-title":"Curr Opin Pulm Med"},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1164\/RCCM.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser\u00a0ED, Maier\u00a0LA, Baughman\u00a0RP et\u00a0al (2020) Diagnosis and detection of Sarcoidosis an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med 201:E26\u2013E51. https:\/\/doi.org\/10.1164\/RCCM.202002-0251ST","journal-title":"Am J Respir Crit Care Med"},{"key":"1338_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00393-017-0312-6","volume":"76","author":"B Ehrenstein","year":"2017","unstructured":"Ehrenstein\u00a0B, Brochhausen\u00a0C (2017) Differenzialdiagnose granulomat\u00f6ser Erkrankungen. Z\u00a0Rheumatol 76:415\u2013424. https:\/\/doi.org\/10.1007\/s00393-017-0312-6","journal-title":"Z Rheumatol"},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1164\/ajrccm\/148.2.483","volume":"148","author":"S Gilbert","year":"1993","unstructured":"Gilbert\u00a0S, Steinbrech\u00a0DS, Landas\u00a0SK, Hunninghake\u00a0GW (1993) Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 148:483\u2013486. https:\/\/doi.org\/10.1164\/ajrccm\/148.2.483","journal-title":"Am Rev Respir Dis"},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1164\/ajrccm.156.1.9612011","volume":"156","author":"H Tomita","year":"1997","unstructured":"Tomita\u00a0H, Ina\u00a0Y, Sugiura\u00a0Y et al (1997) Polymorphism in the Angiotensin-Converting Enzyme (ACE) Gene and Sarcoidosis. Am J Respir Crit Care Med 156:255\u2013259","journal-title":"Am J Respir Crit Care Med"},{"key":"1338_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","volume":"109","author":"ADM Vorselaars","year":"2015","unstructured":"Vorselaars\u00a0ADM, Van Moorsel\u00a0CHM, Zanen\u00a0P et al (2015) ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir Med 109:279\u2013285. https:\/\/doi.org\/10.1016\/j.rmed.2014.11.009","journal-title":"Respir Med"},{"key":"1338_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108515","author":"J Damoiseaux","year":"2020","unstructured":"Damoiseaux\u00a0J (2020) The IL-2\u2014IL\u20112 receptor pathway in health and disease: The role of the soluble IL\u20112 receptor. Clin Immunol. https:\/\/doi.org\/10.1016\/j.clim.2020.108515","journal-title":"Clin Immunol"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1378\/chest.09-1975","volume":"137","author":"S Miyoshi","year":"2010","unstructured":"Miyoshi\u00a0S, Hamada\u00a0H, Kadowaki\u00a0T et\u00a0al (2010) Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest 137:1391\u20131397. https:\/\/doi.org\/10.1378\/chest.09-1975","journal-title":"Chest"},{"key":"1338_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223897","author":"LEM Eurelings","year":"2019","unstructured":"Eurelings\u00a0LEM, Miedema\u00a0JR, Dalm\u00a0VASH et al (2019) Sensitivity and specificity of serum soluble interleukin\u20112 receptor for diagnosing sarcoidosis in a\u00a0population of patients suspected of sarcoidosis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0223897","journal-title":"PLoS ONE"},{"key":"1338_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.36141\/svdld.v37i1.8313","volume":"37","author":"J Miyata","year":"2020","unstructured":"Miyata\u00a0J, Ogawa\u00a0T, Tagami\u00a0Y et al (2020) Serum soluble interleukin\u20112 receptor level is a\u00a0predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 37:8\u201316. https:\/\/doi.org\/10.36141\/svdld.v37i1.8313","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"1338_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-2007-970335","volume":"28","author":"MA Judson","year":"2007","unstructured":"Judson\u00a0MA (2007) Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 28:83\u2013101. https:\/\/doi.org\/10.1055\/s-2007-970335","journal-title":"Semin Respir Crit Care Med"},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"e7595","DOI":"10.1097\/MD.0000000000007595","volume":"96","author":"J Ma\u00f1\u00e1","year":"2017","unstructured":"Ma\u00f1\u00e1\u00a0J, Rubio-Rivas\u00a0M, Villalba\u00a0N et al (2017) Multidisciplinary approach and long-term follow-up in a\u00a0series of 640\u00a0consecutive patients with sarcoidosis. Medicine 96:e7595. https:\/\/doi.org\/10.1097\/MD.0000000000007595","journal-title":"Medicine"},{"key":"1338_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/1025448x.00032012","author":"K Ohara","year":"2005","unstructured":"Ohara\u00a0K, Judson\u00a0MA, Baughman\u00a0RP (2005) Clinical aspects of ocular sarcoidosis. Eur Respir Monogr. https:\/\/doi.org\/10.1183\/1025448x.00032012","journal-title":"Eur Respir Monogr"},{"key":"1338_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01191-x.","author":"HS Te","year":"2020","unstructured":"Te\u00a0HS, Perlman\u00a0DM, Shenoy\u00a0C et\u00a0al (2020) Clinical characteristics and organ system involvement in sarcoidosis : comparison of the University of Minnesota Cohort with other cohorts. BMC Pulm Med. https:\/\/doi.org\/10.1186\/s12890-020-01191-x","journal-title":"BMC Pulm Med"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NRL.0b013e3181c92a72","volume":"16","author":"V Terushkin","year":"2010","unstructured":"Terushkin\u00a0V, Stern\u00a0BJ, Judson\u00a0MA et\u00a0al (2010) Neurosarcoidosis: presentations and management. Neurologist 16:2\u201315. https:\/\/doi.org\/10.1097\/NRL.0b013e3181c92a72","journal-title":"Neurologist"},{"key":"1338_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JC Scadding","year":"1961","unstructured":"Scadding\u00a0JC (1961) Prognosis of intrathoracic sarcoidosis in England. A review of 136\u00a0cases after five years\u2019 observation. Br Med\u00a0J 2:1165\u20131172. https:\/\/doi.org\/10.1136\/bmj.2.5261.1165","journal-title":"Br Med J"},{"key":"1338_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-2007-970336","volume":"28","author":"H Nunes","year":"2007","unstructured":"Nunes\u00a0H, Brillet\u00a0PY, Valeyre\u00a0D et\u00a0al (2007) Imaging in sarcoidosis. Semin Respir Crit Care Med 28:102\u2013120. https:\/\/doi.org\/10.1055\/s-2007-970336","journal-title":"Semin Respir Crit Care Med"},{"key":"1338_CR29","first-page":"268","volume":"30","author":"J Ma\u00f1\u00e1","year":"2013","unstructured":"Ma\u00f1\u00e1\u00a0J, Marcoval\u00a0J, Rubio\u00a0M et\u00a0al (2013) Granulomatous cutaneous sarcoidosis: diagnosis, relationship to systemic disease, prognosis and treatment. Sarcoidosis Vasc Diffuse Lung Dis 30:268\u2013281","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"1338_CR30","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/jdv.13760","volume":"30","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert\u00a0P, Wetter\u00a0DA, Crowson\u00a0CS, Matteson\u00a0EL (2016) Epidemiology of cutaneous sarcoidosis, 1976\u20132013: a\u00a0population-based study from Olmsted County, Minnesota. J\u00a0Eur Acad Dermatology Venereol 30:1799\u20131804. https:\/\/doi.org\/10.1111\/jdv.13760","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/J.AUTREV.2014.04.001","volume":"13","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux\u00a0Y, Kodjikian\u00a0L, Broussolle\u00a0C, S\u00e8ve\u00a0P (2014) Sarcoidosis and uveitis. Autoimmun Rev 13:840\u2013849. https:\/\/doi.org\/10.1016\/J.AUTREV.2014.04.001","journal-title":"Autoimmun Rev"},{"key":"1338_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MCP.0000000000000504","volume":"24","author":"R Bergner","year":"2018","unstructured":"Bergner\u00a0R, L\u00f6ffler\u00a0C (2018) Renal sarcoidosis: approach to diagnosis and management. Curr Opin Pulm Med 24:513\u2013520. https:\/\/doi.org\/10.1097\/MCP.0000000000000504","journal-title":"Curr Opin Pulm Med"},{"key":"1338_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","volume":"88","author":"M Mah\u00e9vas","year":"2009","unstructured":"Mah\u00e9vas\u00a0M, Lescure\u00a0FX, Boffa\u00a0JJ et\u00a0al (2009) Renal sarcoidosis: clinical, laboratory, and histologic presentation and utcome in 47\u00a0patients. Medicine 88:98\u2013106. https:\/\/doi.org\/10.1097\/MD.0b013e31819de50f","journal-title":"Medicine"},{"key":"1338_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.00991-2017","volume":"51","author":"JC Schupp","year":"2018","unstructured":"Schupp\u00a0JC, Freitag-Wolf\u00a0S, Bargagli\u00a0E et al (2018) Phenotypes of organ involvement in sarcoidosis. Eur Respir\u00a0J 51:1\u201311. https:\/\/doi.org\/10.1183\/13993003.00991-2017","journal-title":"Eur Respir J"},{"key":"1338_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin\u00a0R, Lehtonen\u00a0J, Airaksinen\u00a0J et\u00a0al (2015) Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25\u00a0years in a\u00a0nationwide study. Circulation 131:624\u2013632. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/a-1031-4588","volume":"74","author":"D Skowasch","year":"2020","unstructured":"Skowasch\u00a0D, Gaertner\u00a0F, Marx\u00a0N et\u00a0al (2020) Diagnostics and treatment of cardiac Sarcoidosis: consensus paper of the German respiratory society (DGP) and the German cardiac society (DGK). Pneumologie 74:24\u201334. https:\/\/doi.org\/10.1055\/a-1031-4588","journal-title":"Pneumologie"},{"key":"1338_CR37","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","volume":"45","author":"J Smedema","year":"2005","unstructured":"Smedema\u00a0J, Nt\u00a0MMEDI, Sa\u00a0FCP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac Sarcoidosis. J\u00a0Am Coll Cardiol 45:1683\u20131690. https:\/\/doi.org\/10.1016\/j.jacc.2005.01.047","journal-title":"J Am Coll Cardiol"},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","volume":"150","author":"H Ardehali","year":"2005","unstructured":"Ardehali\u00a0H, Howard\u00a0DL, Hariri\u00a0A et\u00a0al (2005) A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart\u00a0J 150:459\u2013463. https:\/\/doi.org\/10.1016\/j.ahj.2004.10.006","journal-title":"Am Heart J"},{"key":"1338_CR39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00393-017-0313-5","volume":"76","author":"P Korsten","year":"2017","unstructured":"Korsten\u00a0P, Chehab\u00a0G (2017) Muskuloskelettale Manifestationen der Sarkoidose. Z\u00a0Rheumatol 76:408\u2013414. https:\/\/doi.org\/10.1007\/s00393-017-0313-5","journal-title":"Z Rheumatol"},{"key":"1338_CR40","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"American Thoracic Society","year":"1999","unstructured":"American Thoracic Society (1999) Statement on Sarcoidosis; ATS\/ERS\/WASGOG. Am J Resp Crit Care Med 160:736\u2013755","journal-title":"Am J Resp Crit Care Med"},{"key":"1338_CR41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","author":"RP Baughman","year":"2021","unstructured":"Baughman\u00a0RP, Valeyre\u00a0D, Korsten\u00a0P et\u00a0al (2021) ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.04079-2020","journal-title":"Eur Respir J"},{"key":"1338_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001114.pub2","author":"NS Paramothayan","year":"2005","unstructured":"Paramothayan\u00a0NS, Lasserson\u00a0TJ, Jones\u00a0P (2005) Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001114.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1338_CR43","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.lpm.2011.12.017","volume":"41","author":"K Nozaki","year":"2012","unstructured":"Nozaki\u00a0K, Judson\u00a0MA (2012) Neurosarcoidosis: Clinical manifestations, diagnosis and treatment. Presse Med 41:e331\u2013e348. https:\/\/doi.org\/10.1016\/j.lpm.2011.12.017","journal-title":"Presse Med"},{"key":"1338_CR44","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/ndt\/gft442","volume":"29","author":"I Hilderson","year":"2014","unstructured":"Hilderson\u00a0I, Van Laecke\u00a0S, Wauters\u00a0A, Donck\u00a0J (2014) Treatment of renal sarcoidosis: Is there a\u00a0guideline? Overview of the different treatment options. Nephrol Dial Transplant 29:1841\u20131847. https:\/\/doi.org\/10.1093\/ndt\/gft442","journal-title":"Nephrol Dial Transplant"},{"key":"1338_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12016-015-8492-9","volume":"49","author":"RP Baughman","year":"2015","unstructured":"Baughman\u00a0RP, Lower\u00a0EE (2015) Treatment of Sarcoidosis. Clin Rev Allergy Immunol 49:79\u201392. https:\/\/doi.org\/10.1007\/s12016-015-8492-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"1338_CR46","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","volume":"138","author":"CE Broos","year":"2018","unstructured":"Broos\u00a0CE, Poell\u00a0LHC, Looman\u00a0CWN et al (2018) No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis. Respir Med 138:S31\u2013S37. https:\/\/doi.org\/10.1016\/j.rmed.2017.10.022","journal-title":"Respir Med"},{"key":"1338_CR47","first-page":"60","volume":"17","author":"RP Baughman","year":"2000","unstructured":"Baughman\u00a0RP, Winget\u00a0DB, Lower\u00a0EE (2000) Methotrexate is steroid sparing in acute sarcoidosis: results of a\u00a0double blind, randomized trial. Sarcoidosis Vasc Diffus Lung Dis 17:60\u201366","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"1338_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1378\/chest.12-1728","volume":"144","author":"ADM Vorselaars","year":"2013","unstructured":"Vorselaars\u00a0ADM, Wuyts\u00a0WA, Vorselaars\u00a0VMM et al (2013) Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest 144:805\u2013812. https:\/\/doi.org\/10.1378\/chest.12-1728","journal-title":"Chest"},{"key":"1338_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.36141\/svdld.v36i3.8449","volume":"36","author":"C Fang","year":"2019","unstructured":"Fang\u00a0C, Zhang\u00a0Q, Wang\u00a0N et al (2019) Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study. Sarcoidosis Vasc Diffuse Lung Dis 36:217\u2013227. https:\/\/doi.org\/10.36141\/svdld.v36i3.8449","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"1338_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071289","author":"V Gavrysyuk","year":"2021","unstructured":"Gavrysyuk\u00a0V, Merenkova\u00a0I, Dziublyk\u00a0Y et al (2021) Efficacy and tolerability of methotrexate and methylprednisolone in a\u00a0comparative assessment of the primary and long-term outcomes in patients with pulmonary sarcoidosis. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics11071289","journal-title":"Diagnostics"},{"key":"1338_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12890-020-01290-9","volume":"20","author":"V Kahlmann","year":"2020","unstructured":"Kahlmann\u00a0V, Janssen Bon\u00e1s\u00a0M, Moor\u00a0CC et al (2020) Design of a\u00a0randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study. BMC Pulm Med 20:271. https:\/\/doi.org\/10.1186\/s12890-020-01290-9","journal-title":"BMC Pulm Med"},{"key":"1338_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","volume":"47","author":"Y Jamilloux","year":"2017","unstructured":"Jamilloux\u00a0Y, Cohen-Aubart\u00a0F, Chapelon-Abric\u00a0C et al (2017) Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132\u00a0patients. Semin Arthritis Rheum 47:288\u2013294. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.03.005","journal-title":"Semin Arthritis Rheum"},{"key":"1338_CR53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman\u00a0RP, Drent\u00a0M, Kavuru\u00a0M et\u00a0al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795\u2013802. https:\/\/doi.org\/10.1164\/rccm.200603-402OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1338_CR54","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1183\/09031936.00051907","volume":"31","author":"MA Judson","year":"2008","unstructured":"Judson\u00a0MA, Baughman\u00a0RP, Costabel\u00a0U et\u00a0al (2008) Efficacy of infliximab in extrapulmonary sarcoidosis: results from a\u00a0randomised trial. Eur Respir\u00a0J 31:1189\u20131196. https:\/\/doi.org\/10.1183\/09031936.00051907","journal-title":"Eur Respir J"},{"key":"1338_CR55","first-page":"201","volume":"23","author":"MD Rossman","year":"2006","unstructured":"Rossman\u00a0MD, Newman\u00a0LS, Baughman\u00a0RP et al (2006) A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23:201\u2013208","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"1338_CR56","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1183\/09031936.00224513","volume":"43","author":"NJ Sweiss","year":"2014","unstructured":"Sweiss\u00a0NJ, Lower\u00a0EE, Mirsaeidi\u00a0M et\u00a0al (2014) Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Respir\u00a0J 43:1525\u20131528. https:\/\/doi.org\/10.1183\/09031936.00224513","journal-title":"Eur Respir J"},{"key":"1338_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30615-x","author":"W Damsky","year":"2022","unstructured":"Damsky\u00a0W, Wang\u00a0A, Kim\u00a0DJ et\u00a0al (2022) Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-30615-x","journal-title":"Nat Commun"},{"key":"1338_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00408-021-00436-8","volume":"199","author":"MA Friedman","year":"2021","unstructured":"Friedman\u00a0MA, Le\u00a0B, Stevens\u00a0J et al (2021) Tofacitinib as a\u00a0steroid-sparing therapy in pulmonary Sarcoidosis, an open-label prospective proof-of-concept study. Am J Physiol 199:147\u2013153. https:\/\/doi.org\/10.1007\/s00408-021-00436-8","journal-title":"Am J Physiol"},{"key":"1338_CR59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11940-013-0242-9","volume":"15","author":"K Nozaki","year":"2013","unstructured":"Nozaki\u00a0K, Judson\u00a0MA (2013) Neurosarcoidosis. Curr Treat Options Neurol 15:492\u2013504. https:\/\/doi.org\/10.1007\/s11940-013-0242-9","journal-title":"Curr Treat Options Neurol"},{"key":"1338_CR60","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","volume":"57","author":"K Bechman","year":"2018","unstructured":"Bechman\u00a0K, Christidis\u00a0D, Walsh\u00a0S et\u00a0al (2018) A review of the musculoskeletal manifestations of sarcoidosis. Rheumatology 57:777\u2013783. https:\/\/doi.org\/10.1093\/rheumatology\/kex317","journal-title":"Rheumatology"},{"key":"1338_CR61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0030-1262214","volume":"31","author":"NJ Sweiss","year":"2010","unstructured":"Sweiss\u00a0NJ, Patterson\u00a0K, Sawaqed\u00a0R et\u00a0al (2010) Rheumatologic manifestations of Sarcoidosis. Semin Respir Crit Care Med 31:463\u2013473","journal-title":"Semin Respir Crit Care Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01338-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T11:03:38Z","timestamp":1686654218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01338-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"9 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>R.\u00a0Bergner<\/b>: A.\u00a0Finanzielle Interessen: R.\u00a0Bergner gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Chefarzt der Medizinischen Klinik\u00a0A\u00a0\u2013 Fachbereich Nephrologie\/Rheumatologie Klinikum Ludwigshafen | Mitgliedschaften: Kommission f\u00fcr studentische Ausbildung der DGRh, DGRh, DEGUM, Vorstandsmitglied der Landesarbeitsgemeinschaft f\u00fcr Rheumatologie Rheinland-Pfalz und Saarland (ARRP), Mitglied im Beirat der Saarl\u00e4ndisch-Pf\u00e4lzischen Gesellschaft f\u00fcr Innere Medizin (SPIG).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}